Concepedia

Naomi Yamahira

NY

Statistics

Publications

3

Citations

168

H-Index

3

Active since

2011

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Naomi Yamahira is an author at Bristol-Myers Squibb (Germany) specializing in clinical pharmacology, pharmacology, and pharmacodynamics.

Publications per year

2011–2015

3

Publications

3

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co‐transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus

Sreeneeranj Kasichayanula, Ming Chang, Mayumi Hasegawa et al. · Diabetes Obesity and Metabolism · 2011 · 115 citations

, , +17

Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects

Naomi Yamahira, Charles Frost, Hiroyuki Fukase et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 42 citations

, , +13

Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects

Tomomi Shiozaki, Takayo Ueno, Hirotaka Nagashima et al. · International Journal of Clinical Pharmacology and Therapeutics · 2015 · 11 citations

, , +8

1–3 of 3